Tonix Pharmaceuticals names CEO Seth Lederman as interim chief medical officerAug 18PeopleTonix Pharmaceuticals, Inc.
Tonix reports Q2 2026 results, TONMYA sales rise 197%, HORIZON trial beginsAug 10Quarterly updatecyclobenzaprineTonix Pharmaceuticals, Inc.
Tonix says FDA aligns on Phase 2 design for Lyme antibody TNX-4800Aug 3Quarterly updateTonix Pharmaceuticals, Inc.
Yale registers Phase 2 trial of Tonix's TNX-1900 for pituitary surgery painJul 28Trial updateTonix Pharmaceuticals, Inc.
Tonix Pharmaceuticals CMO Gregory Sullivan to retire in August 2026Jul 21PeopleTonix Pharmaceuticals, Inc.
Tonix enrolls first patient in Phase 2 depression trial of TNX-102 SLJun 29Clinical readoutcyclobenzaprineTonix Pharmaceuticals, Inc.
